IBDEI08Z ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11856,0)
 ;;=172.9^^74^682^82
 ;;^UTILITY(U,$J,358.3,11856,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11856,1,4,0)
 ;;=4^172.9
 ;;^UTILITY(U,$J,358.3,11856,1,5,0)
 ;;=5^Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,11856,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,11857,0)
 ;;=185.^^74^682^96
 ;;^UTILITY(U,$J,358.3,11857,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11857,1,4,0)
 ;;=4^185.
 ;;^UTILITY(U,$J,358.3,11857,1,5,0)
 ;;=5^Prostate Ca
 ;;^UTILITY(U,$J,358.3,11857,2)
 ;;=Prostate CA^99481
 ;;^UTILITY(U,$J,358.3,11858,0)
 ;;=189.0^^74^682^97
 ;;^UTILITY(U,$J,358.3,11858,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11858,1,4,0)
 ;;=4^189.0
 ;;^UTILITY(U,$J,358.3,11858,1,5,0)
 ;;=5^Renal Cancer
 ;;^UTILITY(U,$J,358.3,11858,2)
 ;;=Renal Cancer^73523
 ;;^UTILITY(U,$J,358.3,11859,0)
 ;;=189.1^^74^682^98
 ;;^UTILITY(U,$J,358.3,11859,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11859,1,4,0)
 ;;=4^189.1
 ;;^UTILITY(U,$J,358.3,11859,1,5,0)
 ;;=5^Renal Pelvis Cancer
 ;;^UTILITY(U,$J,358.3,11859,2)
 ;;=   ^267264
 ;;^UTILITY(U,$J,358.3,11860,0)
 ;;=171.9^^74^682^102
 ;;^UTILITY(U,$J,358.3,11860,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11860,1,4,0)
 ;;=4^171.9
 ;;^UTILITY(U,$J,358.3,11860,1,5,0)
 ;;=5^Soft Tissue Sarcoma
 ;;^UTILITY(U,$J,358.3,11860,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,11861,0)
 ;;=186.9^^74^682^103
 ;;^UTILITY(U,$J,358.3,11861,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11861,1,4,0)
 ;;=4^186.9
 ;;^UTILITY(U,$J,358.3,11861,1,5,0)
 ;;=5^Testicular Cancer
 ;;^UTILITY(U,$J,358.3,11861,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,11862,0)
 ;;=198.7^^74^682^1
 ;;^UTILITY(U,$J,358.3,11862,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11862,1,4,0)
 ;;=4^198.7
 ;;^UTILITY(U,$J,358.3,11862,1,5,0)
 ;;=5^Adrenal Metastasis
 ;;^UTILITY(U,$J,358.3,11862,2)
 ;;=^267337
 ;;^UTILITY(U,$J,358.3,11863,0)
 ;;=198.5^^74^682^14
 ;;^UTILITY(U,$J,358.3,11863,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11863,1,4,0)
 ;;=4^198.5
 ;;^UTILITY(U,$J,358.3,11863,1,5,0)
 ;;=5^Bone Or Bone Marrow Metastasis
 ;;^UTILITY(U,$J,358.3,11863,2)
 ;;=^267336
 ;;^UTILITY(U,$J,358.3,11864,0)
 ;;=198.3^^74^682^16
 ;;^UTILITY(U,$J,358.3,11864,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11864,1,4,0)
 ;;=4^198.3
 ;;^UTILITY(U,$J,358.3,11864,1,5,0)
 ;;=5^Brain Metatastasis
 ;;^UTILITY(U,$J,358.3,11864,2)
 ;;=Brain Metatastasis^267334
 ;;^UTILITY(U,$J,358.3,11865,0)
 ;;=197.7^^74^682^28
 ;;^UTILITY(U,$J,358.3,11865,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11865,1,4,0)
 ;;=4^197.7
 ;;^UTILITY(U,$J,358.3,11865,1,5,0)
 ;;=5^Ca Liver, Secondary
 ;;^UTILITY(U,$J,358.3,11865,2)
 ;;=CA Liver, Secondary^267328
 ;;^UTILITY(U,$J,358.3,11866,0)
 ;;=197.0^^74^682^84
 ;;^UTILITY(U,$J,358.3,11866,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11866,1,4,0)
 ;;=4^197.0
 ;;^UTILITY(U,$J,358.3,11866,1,5,0)
 ;;=5^Mets To Lung
 ;;^UTILITY(U,$J,358.3,11866,2)
 ;;=Mets to Lung^267322
 ;;^UTILITY(U,$J,358.3,11867,0)
 ;;=196.2^^74^682^83
 ;;^UTILITY(U,$J,358.3,11867,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11867,1,4,0)
 ;;=4^196.2
 ;;^UTILITY(U,$J,358.3,11867,1,5,0)
 ;;=5^Mets To Ln, Abdominal
 ;;^UTILITY(U,$J,358.3,11867,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,11868,0)
 ;;=196.3^^74^682^85
 ;;^UTILITY(U,$J,358.3,11868,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11868,1,4,0)
 ;;=4^196.3
 ;;^UTILITY(U,$J,358.3,11868,1,5,0)
 ;;=5^Mets To Lymph Nodes, Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,11868,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,11869,0)
 ;;=196.0^^74^682^86
 ;;^UTILITY(U,$J,358.3,11869,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11869,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,11869,1,5,0)
 ;;=5^Mets To Lymph Nodes, Cervical
 ;;^UTILITY(U,$J,358.3,11869,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,11870,0)
 ;;=196.1^^74^682^87
 ;;^UTILITY(U,$J,358.3,11870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11870,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,11870,1,5,0)
 ;;=5^Mets To Lymph Nodes, Mediastinal 
 ;;^UTILITY(U,$J,358.3,11870,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,11871,0)
 ;;=196.8^^74^682^88
 ;;^UTILITY(U,$J,358.3,11871,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11871,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,11871,1,5,0)
 ;;=5^Mets To Lymph Nodes, Multiple Sites
 ;;^UTILITY(U,$J,358.3,11871,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,11872,0)
 ;;=V10.51^^74^682^46
 ;;^UTILITY(U,$J,358.3,11872,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11872,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,11872,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,11872,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,11873,0)
 ;;=V10.3^^74^682^47
 ;;^UTILITY(U,$J,358.3,11873,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11873,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,11873,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,11873,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,11874,0)
 ;;=V10.41^^74^682^48
 ;;^UTILITY(U,$J,358.3,11874,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11874,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,11874,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,11874,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,11875,0)
 ;;=V10.05^^74^682^49
 ;;^UTILITY(U,$J,358.3,11875,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11875,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,11875,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,11875,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,11876,0)
 ;;=V10.03^^74^682^50
 ;;^UTILITY(U,$J,358.3,11876,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11876,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,11876,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,11876,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,11877,0)
 ;;=V10.60^^74^682^52
 ;;^UTILITY(U,$J,358.3,11877,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11877,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,11877,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,11877,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,11878,0)
 ;;=V10.11^^74^682^53
 ;;^UTILITY(U,$J,358.3,11878,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11878,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,11878,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,11878,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,11879,0)
 ;;=V10.79^^74^682^54
 ;;^UTILITY(U,$J,358.3,11879,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11879,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,11879,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,11879,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,11880,0)
 ;;=V10.82^^74^682^55
 ;;^UTILITY(U,$J,358.3,11880,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11880,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,11880,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,11880,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,11881,0)
 ;;=V10.02^^74^682^56
 ;;^UTILITY(U,$J,358.3,11881,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11881,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,11881,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,11881,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,11882,0)
 ;;=V10.43^^74^682^57
 ;;^UTILITY(U,$J,358.3,11882,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11882,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,11882,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,11882,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,11883,0)
 ;;=V10.46^^74^682^58
 ;;^UTILITY(U,$J,358.3,11883,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11883,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,11883,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,11883,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,11884,0)
 ;;=V10.06^^74^682^59
 ;;^UTILITY(U,$J,358.3,11884,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11884,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,11884,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,11884,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,11885,0)
 ;;=V10.52^^74^682^60
 ;;^UTILITY(U,$J,358.3,11885,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11885,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,11885,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,11885,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,11886,0)
 ;;=V10.04^^74^682^62
 ;;^UTILITY(U,$J,358.3,11886,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11886,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,11886,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,11886,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,11887,0)
 ;;=V10.47^^74^682^63
 ;;^UTILITY(U,$J,358.3,11887,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11887,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,11887,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,11887,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,11888,0)
 ;;=V10.83^^74^682^61
 ;;^UTILITY(U,$J,358.3,11888,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11888,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,11888,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,11888,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,11889,0)
 ;;=285.22^^74^682^7
 ;;^UTILITY(U,$J,358.3,11889,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11889,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,11889,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,11889,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,11890,0)
 ;;=285.21^^74^682^8
 ;;^UTILITY(U,$J,358.3,11890,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11890,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,11890,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,11890,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,11891,0)
 ;;=285.29^^74^682^9
 ;;^UTILITY(U,$J,358.3,11891,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11891,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,11891,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,11891,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,11892,0)
 ;;=284.9^^74^682^10
 ;;^UTILITY(U,$J,358.3,11892,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11892,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,11892,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,11892,2)
 ;;=^7020
